Clinical meaning
Thyroid disorders represent a spectrum of conditions resulting from either insufficient (hypothyroidism) or excessive (hyperthyroidism) thyroid hormone production, with thyroid storm representing the most extreme and life-threatening manifestation of thyrotoxicosis. Understanding the underlying autoimmune mechanisms, thyroid hormone physiology, and the pathological consequences of hormonal imbalance is essential for RN-level clinical practice.
Hypothyroidism — Hashimoto Thyroiditis: Hashimoto thyroiditis (chronic lymphocytic thyroiditis) is the most common cause of hypothyroidism in iodine-sufficient regions, affecting approximately 5% of the population with a 10:1 female-to-male ratio. It is an organ-specific autoimmune disease in which the immune system targets thyroid tissue for destruction. The pathogenesis involves CD4+ T helper cells recognizing thyroid autoantigens (thyroid peroxidase/TPO and thyroglobulin) presented by HLA class II molecules on thyroid follicular cells and infiltrating antigen-presenting cells. This triggers a cascade of immune-mediated destruction: CD8+ cytotoxic T cells directly kill thyrocytes through perforin-granzyme and Fas-FasL pathways; B lymphocytes produce anti-TPO antibodies (present in 90-95% of patients) and anti-thyroglobulin antibodies that fix complement and cause antibody-dependent cell-mediated cytotoxicity (ADCC); inflammatory cytokines (TNF-alpha, IFN-gamma, IL-1) further damage thyroid tissue. Over months to years, progressive follicular destruction reduces thyroid hormone synthesis capacity, leading to compensatory TSH elevation (the earliest biochemical change) and eventually frank hypothyroidism with low free T4. The thyroid gland becomes infiltrated with lymphocytes, plasma cells, and germinal centers, often presenting as a painless, firm goiter.
Hyperthyroidism — Graves Disease: Graves disease is the most common cause of hyperthyroidism, caused by thyroid-stimulating immunoglobulins (TSI) — IgG autoantibodies that bind to and activate the TSH receptor on thyroid follicular cells, mimicking the action of TSH. This constitutive activation of the TSH receptor-Gs protein-adenylate cyclase-cAMP signaling cascade causes: (1) diffuse thyroid hyperplasia and hypertrophy (diffuse goiter); (2) excessive thyroid hormone synthesis and secretion (elevated free T4 and T3); (3) suppressed TSH (negative feedback from high T4/T3). The TSI antibodies are not regulated by negative feedback, so thyroid hormone production is autonomous and continuous. Graves-specific complications include Graves ophthalmopathy (orbital inflammation and fibrosis from TSH receptor expression on orbital fibroblasts and adipocytes, causing proptosis, diplopia, and potentially vision-threatening compressive optic neuropathy) and pretibial myxedema (localized dermopathy from glycosaminoglycan deposition in the skin).